理邦仪器(300206.SZ):2019年净利预增25%-50%
格隆汇1月17日丨理邦仪器(300206.SZ)披露2019年年度业绩预告,公司预计2019年1-12月实现归属于上市公司股东的净利润1.16亿元-1.39亿元,同比增长25%-50%。业绩变动原因说明:
1、报告期内,公司加大国内外市场的开拓力度,持续挖掘各细分市场潜力,加上新兴产品持续发力,营业收入保持稳定增长,本期营业利润较上年同期大幅增加;其中妇幼产品和体外诊断产品线及子公司智慧健康增长趋势良好。
2、公司全面实施精细化管理,挖潜增效,进一步提升管理和运营效率,促进毛利率的提升,同时也强化成本费用控制。
3、报告期公司非经常性损益对净利润影响预计为1400万元左右,主要为政府补助和理财收益。本期政府补助较上年同期减少2560万元左右。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.